학술논문

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial
Document Type
Article
Source
In: Gynecologic Oncology. (Gynecologic Oncology, March 2019, 152(3):560-567)
Subject
Language
English
ISSN
10956859
00908258